These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30237219)

  • 1. Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.
    Kendrick J; Shah P; Andrews E; You Z; Nowak K; Pasch A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1463-1470. PubMed ID: 30237219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial.
    Raphael KL; Katz R; Larive B; Kendrick C; Isakova T; Sprague S; Wolf M; Raj DS; Fried LF; Gassman J; Hoofnagle A; Cheung AK; Ix JH
    J Am Soc Nephrol; 2024 Jan; 35(1):57-65. PubMed ID: 38170601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
    Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
    Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium Bicarbonate Treatment and Vascular Function in CKD: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Kendrick J; You Z; Andrews E; Farmer-Bailey H; Moreau K; Chonchol M; Steele C; Wang W; Nowak KL; Patel N
    J Am Soc Nephrol; 2023 Aug; 34(8):1433-1444. PubMed ID: 37228030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
    Raphael KL
    Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
    Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pilot Study of the Safety and Efficacy of Alkali Therapy on Vascular Function in Kidney Transplant Recipients.
    Bohling R; Grafals M; Moreau K; You Z; Tommerdahl KL; Bjornstad P; Stenson EK; Andrews E; Ramirez-Renteria L; Kendrick J
    Kidney Int Rep; 2021 Sep; 6(9):2323-2330. PubMed ID: 34514193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Mohebbi N; Ritter A; Wiegand A; Graf N; Dahdal S; Sidler D; Arampatzis S; Hadaya K; Mueller TF; Wagner CA; Wüthrich RP
    Lancet; 2023 Feb; 401(10376):557-567. PubMed ID: 36708734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.
    Dubey AK; Sahoo J; Vairappan B; Haridasan S; Parameswaran S; Priyamvada PS
    Nephrol Dial Transplant; 2020 Jan; 35(1):121-129. PubMed ID: 30053298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Serum Bicarbonate and CKD Progression in Children.
    Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
    Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
    J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in management of chronic metabolic acidosis in chronic kidney disease.
    Chen W; Abramowitz MK
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):409-416. PubMed ID: 31232712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium citrate versus sodium bicarbonate for metabolic acidosis in patients with chronic kidney disease: A randomized controlled trial.
    Sorohan BM; Obrișcă B; Jurubiță R; Lupușoru G; Achim C; Andronesi A; Frățilă G; Berechet A; Micu G; Ismail G
    Medicine (Baltimore); 2024 Mar; 103(10):e37475. PubMed ID: 38457574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients.
    Szczecińska K; Wajdlich M; Nowicka M; Nowicki M; Kurnatowska I
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
    Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
    Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study.
    Chen W; Melamed ML; Hostetter TH; Bauer C; Raff AC; Almudevar AL; Lalonde A; Messing S; Abramowitz MK
    BMC Nephrol; 2016 Aug; 17(1):114. PubMed ID: 27495287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of correction of metabolic acidosis on blood urea and bone metabolism in patients with mild to moderate chronic kidney disease: a prospective randomized single blind controlled trial.
    Mathur RP; Dash SC; Gupta N; Prakash S; Saxena S; Bhowmik D
    Ren Fail; 2006; 28(1):1-5. PubMed ID: 16526312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
    Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
    J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.